Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?
- 31 March 2005
- journal article
- review article
- Published by Elsevier BV in Trends in Parasitology
- Vol. 21 (3), 112-117
- https://doi.org/10.1016/j.pt.2005.01.001
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Human schistosomiasis mansoni: intensity of infection differentially affects the production of interleukin-10, interferon-γ and interleukin-13 by soluble egg antigen or adult worm antigen stimulated culturesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2004
- Vaccination of mice with a 30 kDaSchistosomaantigen with and without human adjuvant induces high protection againstS. mansoniinfectionJournal of Helminthology, 2004
- RecombinantMycobacterium bovisBCG Expressing the Sm14 Antigen ofSchistosoma mansoniProtects Mice from Cercarial ChallengeInfection and Immunity, 2004
- Vaccine Strategies against Schistosomiasis: From Concepts to Clinical TrialsInternational Archives of Allergy and Immunology, 2001
- Schistosomiasis Vaccines: The Devils’ Advocate’s Final PleaParasitology Today, 2000
- Characterization of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humansMolecular and Biochemical Parasitology, 1997
- Schistosomiasis Japonica in the Philippines: The Long-Term Impact of Population-Based Chemotherapy on Infection, Transmission, and MorbidityThe Journal of Infectious Diseases, 1996
- Kinetics and mechanism of effector focus formation in the lungs of mice vaccinated with irradiated cercariae of Schistosoma mansoniParasite Immunology, 1996
- Worm burdens in schistosome infectionsParasitology Today, 1996
- Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobiumNature, 1991